Barclays PLC Armata Pharmaceuticals, Inc. Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Barclays PLC holds 6 shares of ARMP stock, worth $42. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6Holding current value
$42% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
755KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA297KShares$2.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$736,0030.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$704,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$314,5610.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny41.3KShares$290,7230.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $254M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...